With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeted Inhibition of Signaling Networks in Pediatric Glioblastoma Stem Cells||University of California Berkeley / Erin Simonds, PhD||Young Investigator Grants||2013||California|
|Investigating the Role of Circadian Rhythm in the Progression of Acute Myeloid Leukemia||Boston Children's Hospital / Samantha Morris, PhD||Young Investigator Grants||2013||Massachusetts|
|Oncogenic Hedgehog Pathway Activation by a Putative Rho GTPase-Activating Protein||Lucile Packard Children's Hospital at Stanford University School of Medicine / Jun Ni, PhD||Young Investigator Grants||2013||California|
|The Role of Prmt1 in Osteosarcoma Initiation and Metastasis||Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD||Young Investigator Grants||2013||Massachusetts|
|PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / Jessica Blackburn, PhD||Young Investigator Grants||2013||Massachusetts|
|Defining the Role of a Novel, Developmentally Restricted Hematopoietic Stem Cell in Pediatric Leukemias||University of California at Santa Cruz / Camilla Forsberg, PhD||Innovation Grants||2013||California|
|Identification of TFAP4 (Transcription Factor AP-4/Activating Enhancer Binding Protein) as a Potential Master Regulator/Synthetic Lethal Gene of MYCN Amplified Neuroblastoma||Columbia University Medical Center / Darrell Yamashiro, MD, PhD||Innovation Grants||2013||New York|
|Therapeutically Targeting a Tumor Suppressor Complex in Aggressive Pediatric Cancers||Dana-Farber Cancer Institute / Charles Roberts, MD, PhD||Innovation Grants||2013||Massachusetts|
|Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia||Massachusetts General Hospital / David Langenau, PhD||Innovation Grants||2013||Massachusetts|
|DICER1, MicroRNAs and Pediatric Cancer: An Emerging Story||Research Institute of the McGill University Health Centre / William Foulkes, MD, PhD||Innovation Grants||2013||Quebec|